News
🌏 NMPA Page 18Latest pharmaceutical news, drug approvals, and NMPA regulatory updates
Showing 205–216 of 238 articles
Australia's TGA Updates Assessed Listed Medicines Framework for Enhanced Pre-Market Evaluation
Corcept Therapeutics Faces FDA Rejection of Relacorilant for Cushing's Syndrome, Investor Lawsuit Filed
Florida Cancer Specialists & Research Institute Advances Medically Integrated Oncology Care Model
Phantom Neuro Receives Approval for First Human Trial of Phantom X Neural Interface System
Phrontline Biopharma's TJ106 Shows Promise Against HER2-Low and Drug-Resistant Cancers in Preclinical Studies
XellSmart Advances XS411 Parkinson's Cell Therapy to Phase II Trial After Positive Phase I Results
Peer AI Launches Advanced Regulatory Platform with Predictive Intelligence for Life Sciences Submissions
WuXi Biologics Achieves ISO 13485 Certification for Drug-Device Combination Products Manufacturing
Atelerix Partners with JH Health to Expand Non-Cryogenic Cell Preservation Technology in Middle East
Chitosan Market Surges 14.3% CAGR as KitoZyme, Primex Lead $7.6B Pharmaceutical Biopolymer Boom by 2036
Telix Pharmaceuticals Doses First Patient in Phase 3 Trial of TLX101-Tx for Recurrent Glioblastoma
NMN 500mg Energy Support Supplement Receives TGA Approval in Australia